Item 9 Labs (INLB) EBT (2016 - 2023)
Item 9 Labs' EBT history spans 12 years, with the latest figure at -$5.9 million for Q2 2023.
- For Q2 2023, EBT fell 8.1% year-over-year to -$5.9 million; the TTM value through Jun 2023 reached -$31.0 million, down 42.83%, while the annual FY2022 figure was -$31.2 million, 185.77% down from the prior year.
- EBT reached -$5.9 million in Q2 2023 per INLB's latest filing, down from -$3.4 million in the prior quarter.
- In the past five years, EBT ranged from a high of $49020.0 in Q1 2021 to a low of -$18.5 million in Q3 2022.
- Average EBT over 5 years is -$4.3 million, with a median of -$3.3 million recorded in 2021.
- Peak YoY movement for EBT: surged 103.11% in 2021, then plummeted 7993.37% in 2022.
- A 5-year view of EBT shows it stood at -$2.0 million in 2019, then soared by 45.61% to -$1.1 million in 2020, then crashed by 211.32% to -$3.3 million in 2021, then rose by 3.02% to -$3.2 million in 2022, then plummeted by 82.39% to -$5.9 million in 2023.
- Per Business Quant, the three most recent readings for INLB's EBT are -$5.9 million (Q2 2023), -$3.4 million (Q1 2023), and -$3.2 million (Q4 2022).